The tables have turned for jobs in medicinal chemistry. Traditionally, such skills were in demand at pharmaceutical companies, where medicinal chemists would be expected to come up with new molecules. Biotechnology companies, by contrast, preferred molecular biologists who could search for protein-based therapeutics. But, helped by several economic factors, these distinctions are now becoming blurred.
展开▼
